| Literature DB >> 26884494 |
Madhukar Pai1, Amrita Daftary2, Srinath Satyanarayana2.
Abstract
India's TB control programme has treated over 19 million patients, but the incidence of TB continues to be high. TB is a major killer and drug-resistant TB is a growing threat. There are several likely reasons, including social conditions and co-morbidities that fuel the TB epidemic: under-investment by the government, weak programme implementation and management, suboptimal quality of care in the private sector, and insufficient advocacy around TB. Fortunately, India possesses the technical know-how, competence and resources to address these challenges. The End TB Strategy by WHO offers India an excellent blueprint to advance the agenda of TB control.Entities:
Keywords: India; TB control; Tuberculosis
Mesh:
Substances:
Year: 2016 PMID: 26884494 PMCID: PMC5916376 DOI: 10.1093/trstmh/trw003
Source DB: PubMed Journal: Trans R Soc Trop Med Hyg ISSN: 0035-9203 Impact factor: 2.184